Ptc Therapeutics (PTCT) Net Margin Growth (3y) (2015 - 2026)
Ptc Therapeutics (PTCT) Net Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,283.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 4,144.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Ptc Therapeutics | 6.34 Bn | 4.45 Bn | 244.52 Mn | 6,202.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,202.00 |
| Dec 31, 2025 | 2,594.00 |
| Sep 30, 2025 | 5,788.00 |
| Jun 30, 2025 | 5,563.00 |
| Mar 31, 2025 | 15,888.00 |
| Dec 31, 2024 | 5,580.00 |
| Sep 30, 2024 | 4,211.00 |
| Mar 31, 2024 | 6,549.00 |
| Dec 31, 2023 | -43,204.00 |
| Sep 30, 2023 | -878.00 |
| Jun 30, 2023 | 14,811.00 |
| Mar 31, 2023 | 10,203.00 |
| Dec 31, 2022 | -30,335.00 |
| Sep 30, 2022 | 3,372.00 |
| Jun 30, 2022 | 9.08 Mn |
| Mar 31, 2022 | 5,072.00 |
| Dec 31, 2021 | -3,032.00 |
| Sep 30, 2021 | -18.00 |
| Jun 30, 2021 | 155,998.00 |
| Mar 31, 2021 | -7,466.00 |